Today is Saturday, Jul. 20, 2019

Department of

Radiation Oncology - Takiar & Wise-Draper Laboratory

Former Lab Members


Benyamin Yaniv, BS

Research Assistant

Ben received his BS in Biology from the University of Cincinnati in 2015. During his undergraduate degree, he conducted his research under the mentorship of Dr. Michael Borchers studying the effects of cigarette smoke on COPD patients. After graduating, Ben joined the Takiar-Wise Draper lab in August 2016. Ben is currently evaluating patient samples from ongoing clinical trials and the role of the oncogene DEK in the immune system. He is currently attending medical school.


Melissa Asman

Research Associate

Research Associate Melissa Asman has long been a member of the UC research community. Specializing in animal models and westerns, she assisted with preliminary in vivo radiation experiments as well as flow cytometry. She has taken another position within the University.


Sulsal Haque, MD

Former Hematology-Oncology Fellow

During his time as a Hematology-Oncology fellow, Sulsal completed a retrospective evaluation of prognostic factors at the time of salvage surgery for recurrent head and neck cancer. He subsequently designed an investigator initiated trial (IIT) evaluating the use of adjuvant Nivolumab (anti-PD-1 therapy) following salvage surgery in head and neck cancer patients under the mentorship of Drs. Wise-Draper and Takiar. He has since taken a position at Merck.


Suchin Khanna, MD

Former Internal Medicine Resident

During his time as an Internal Medicine resident, Suchin designed a retrospective study examining molecular markers in HPV16 positive oropharyngeal HNSCC patients who had undergone primary surgical resection to assess whether these markers can predict recurrence. He has since transitioned to a hematology/oncology fellowship at Yale.


Chandler Robinson, BS

Research Assistant

Chandler is a 2018 graduate of the University of Cincinnati, receiving a BS in Neurobiology and a minor in Medical Sciences. For the majority of his undergraduate research experience, Chandler worked on preclinical validation of pharmacologic treatment in mouse models of Autism Spectrum Disorders, primarily Fragile X Syndrome, and worked to better understand disease pathophysiology by developing and implementing protocols for immunohistochemistry to assess aberrant protein localization and protein quantity. His research mainly focused on studying alterations in microglial dependent synaptic remodeling using the developing retinogeniculate system as a model. Chandler joined the lab in August, 2017 and currently processes all patient samples. He is also developing and optimizing assays for better protein quantification.